File photo

B.C. company gets licence to test psychedelic drugs for therapy treatment

Salvation Botanicals interested in manufacturing, testing and research and development

A Nanaimo company has been granted a licence to test and analyze psychedelic drugs.

Salvation Botanicals’ Nanaimo lab has been granted a controlled drugs and substances dealer’s licence to test psychedelics such as psilocybin, mescaline and MDMA, said Michael Tan, the company’s CEO, in an e-mail to the News Bulletin.

The licence authorizes possession, testing, sale, sending, transportation and delivery of psilocybin, psilocin, mescaline, dimethyltryptamine (DMT), and methylenedioxyamphetamine (MDMA), according to a press release.

Although the licence authorizes sale of the psychedelics, Tan noted in the e-mail that at this point, the drugs can only be provided to those authorized to conduct research and development and clinical trials.

Salvation has partnered with Vancouver-based Numinus, which according to the release “aims to facilitate guided psychedelic therapy for individuals suffering from mental health issues, addiction, and trauma.”

“Psychedelics for the treatment of mental health issues is a topic of high interest now, and Salvation is proud to be at the forefront of this space,” Tan said, adding in the release that Salvation Botanicals is “strategically positioned to become a leader in controlled substances testing in Canada by providing scientific expertise and a commitment to our partner’s success through an efficient and consultative approach.”

Tan noted that a Phase 3 clinical trial of MDMA for patients suffering from post-traumatic stress disorder will begin soon through the B.C. Centre on Substance Use.

“Looking ahead beyond the Phase 3 clinical trial stage is the prospect of public use,” he said.

He said Numinus is positioning itself as a channel for psychedelics-based therapy at clinics it plans to set up, and at that point, Salvation could potentially participate through research and development, testing and manufacturing.



editor@nanaimobulletin.com

Like us on Facebook and follow us on Twitter

Just Posted

Slow down for students: School zone speeds now in effect

RCMP will be making sure drivers keep it at 30 km/h or less, with heavy fines for breaking the law

Queen Charlotte fire hall is a go

Start of construction marked with groundbreaking ceremony

NCRD Board turns attention to Haida Gwaii

Fishing concerns, recreation commission, and Sandspit festival all receive focus

IV cancer treatment returning to Haida Gwaii

Arrival of a new pharmacy technician means the service can resume

Logging moves forward as court rules against Haida Gwaii protesters

Injunction won against activists seeking to protect culturally and archaeologically significant site

VIDEO: #MeToo leader launches new hashtag to mobilize U.S. voters

Tarana Burke hopes to prompt moderators to ask about sexual violence at next debate

Potent power play paces Canucks to 5-1 win over Detroit

Miller nets a pair as Vancouver wins third straight

UPDATE: British couple vacationing in Vancouver detained in U.S. after crossing border

CBP claims individuals were denied travel authorization, crossing was deliberate

After losing two baby boys, B.C. parents hope to cut through the taboo of infant death

Oct. 15 is Pregnancy and Infant Loss Awareness Day in B.C.

Cheating husband sues mistress for gifted ring after wife learns about affair

The husband gave his mistress $1,000 to buy herself a ring in December 2017

B.C. massage therapist reprimanded, fined for exposing patients’ breasts

Registered massage therapist admits professional misconduct

B.C. boosts legal aid funding in new payment contract

‘Duty counsel’ service restored in some communities, David Eby says

Rugby Canada helps recovery efforts in Japan after typhoon cancels final match

Canadian players wanted to “give back in whatever small way they could”

Alberta to join B.C.’s class-action lawsuit against opioid manufacturers, distributors

B.C. government claims opioids were falsely marketed as less addictive than other pain meds

Most Read